DRUG · Unmapped registry intervention
AGSAV301
Find medicine records ·
Find other trials using this name
Clinical trial
Clinical Trial to Evaluate the Bioavailability and Safety of AGSAV301
NCT01536353
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Exforge 10/160
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedClinical Trial to Evaluate the Bioavailability and Safety of AGSAV301
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Hypertensionunresolved
Interventions
AGSAV301DRUG
Exforge 10/160DRUG
Sponsors & collaborators
Ahn-Gook Pharmaceuticals Co.,Ltdlead sponsor
Asan Medical Centercollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01536353 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.